Key result
Author reply addresses unanswered clinical questions regarding platelet-activating factor acetylhydrolase in ARDS.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Unresolved PAF-AH questions in ARDS warrant clinical caution; leaves open need for targeted trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Grissom et al. (2004) studied this question. Platelet-activating factor acetylhydrolase's role in acute respiratory distress syndrome involves unanswered clinical questions addressed in this author reply.
Synapse has enriched 10 related papers. Consider them for comparative context: